Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 949 to 960 of 961 entries
Sorted by: Best Match Show Resources per page
Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study.

Advances in therapy

Assouline O, Ben-Chetrit E, Helviz Y, Kurd R, Leone M, Einav S.
PMID: 34424502
Adv Ther. 2021 Oct;38(10):5165-5177. doi: 10.1007/s12325-021-01890-9. Epub 2021 Aug 22.

INTRODUCTION: Concomitant experimental/compassionate drug administration has been all-pervasive in the treatment of COVID-19 patients. The objective of this study was to study the relationship between patient severity, the number of experimental/compassionate medications received (main outcome measure), and patient outcomes...

Cite
Assouline O, Ben-Chetrit E, Helviz Y, et al. Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study. Adv Ther. 2021;38(10):5165-5177doi: 10.1007/s12325-021-01890-9.
Assouline, O., Ben-Chetrit, E., Helviz, Y., Kurd, R., Leone, M., & Einav, S. (2021). Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study. Advances in therapy, 38(10), 5165-5177. https://doi.org/10.1007/s12325-021-01890-9
Assouline, Or, et al. "Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study." Advances in therapy vol. 38,10 (2021): 5165-5177. doi: https://doi.org/10.1007/s12325-021-01890-9
Assouline O, Ben-Chetrit E, Helviz Y, Kurd R, Leone M, Einav S. Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study. Adv Ther. 2021 Oct;38(10):5165-5177. doi: 10.1007/s12325-021-01890-9. Epub 2021 Aug 22. PMID: 34424502; PMCID: PMC8381349.
Copy Download .nbib Format: NLM
Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration.

Mathematical biosciences and engineering : MBE

Parajdi LG, Precup R, Şerban MA, Haplea IŞ.
PMID: 33757214
Math Biosci Eng. 2021 Feb 22;18(2):1845-1863. doi: 10.3934/mbe.2021096.

A complete stability analysis of the equilibrium solutions of a system modeling tumor chemotherapy is performed in two cases of administration of the treatment, by continuous infusion and by periodic infusion. Several numerical simulations illustrate and complement the theory.

Cite
Parajdi LG, Precup R, Şerban MA, et al. Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration. Math Biosci Eng. 2021;18(2):1845-1863doi: 10.3934/mbe.2021096.
Parajdi, L. G., Precup, R., Şerban, M. A., & Haplea, I. �. �. (2021). Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration. Mathematical biosciences and engineering : MBE, 18(2), 1845-1863. https://doi.org/10.3934/mbe.2021096
Parajdi, Lorand Gabriel, et al. "Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration." Mathematical biosciences and engineering : MBE vol. 18,2 (2021): 1845-1863. doi: https://doi.org/10.3934/mbe.2021096
Parajdi LG, Precup R, Şerban MA, Haplea IŞ. Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration. Math Biosci Eng. 2021 Feb 22;18(2):1845-1863. doi: 10.3934/mbe.2021096. PMID: 33757214.
Copy Download .nbib Format: NLM
[Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs].

Annales pharmaceutiques francaises

Bailly M, Queuille E, Juillard-Condat B, Paubel P.
PMID: 33713639
Ann Pharm Fr. 2021 Nov;79(6):690-699. doi: 10.1016/j.pharma.2021.03.002. Epub 2021 Mar 11.

Pharmacotherapeutic care is now expanding in public mental health institutions. Annual grants are funding the public psychiatric field, hindering access to therapeutic innovation and expensive medications due to long length of stay. On the threshold of the French Healthcare...

Cite
Bailly M, Queuille E, Juillard-Condat B, et al. Analyse comparative du financement des établissements de soins de suite et réadaptation et des établissements publics de santé mentale : application pour les médicaments innovants et onéreux. [Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs]. Ann Pharm Fr. 2021;79(6):690-699doi: 10.1016/j.pharma.2021.03.002.
Bailly, M., Queuille, E., Juillard-Condat, B., & Paubel, P. (2021). Analyse comparative du financement des établissements de soins de suite et réadaptation et des établissements publics de santé mentale : application pour les médicaments innovants et onéreux. [Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs]. Annales pharmaceutiques francaises, 79(6), 690-699. https://doi.org/10.1016/j.pharma.2021.03.002
Bailly, M, et al. "Analyse comparative du financement des établissements de soins de suite et réadaptation et des établissements publics de santé mentale : application pour les médicaments innovants et onéreux." [Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs]. Annales pharmaceutiques francaises vol. 79,6 (2021): 690-699. doi: https://doi.org/10.1016/j.pharma.2021.03.002
Bailly M, Queuille E, Juillard-Condat B, Paubel P. Analyse comparative du financement des établissements de soins de suite et réadaptation et des établissements publics de santé mentale : application pour les médicaments innovants et onéreux. [Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs]. Ann Pharm Fr. 2021 Nov;79(6):690-699. doi: 10.1016/j.pharma.2021.03.002. Epub 2021 Mar 11. French. PMID: 33713639.
Copy Download .nbib Format: NLM
Drug companies need better oversight but have also provided excellent protection.

BMJ (Clinical research ed.)

Bussey GD.
PMID: 34857542
BMJ. 2021 Dec 02;375:n2950. doi: 10.1136/bmj.n2950.

No abstract available.

Cite
Bussey GD. Drug companies need better oversight but have also provided excellent protection. BMJ. 2021;375:n2950doi: 10.1136/bmj.n2950.
Bussey, G. D. (2021). Drug companies need better oversight but have also provided excellent protection. BMJ (Clinical research ed.), 375n2950. https://doi.org/10.1136/bmj.n2950
Bussey, George D. "Drug companies need better oversight but have also provided excellent protection." BMJ (Clinical research ed.) vol. 375 (2021): n2950. doi: https://doi.org/10.1136/bmj.n2950
Bussey GD. Drug companies need better oversight but have also provided excellent protection. BMJ. 2021 Dec 02;375:n2950. doi: 10.1136/bmj.n2950. PMID: 34857542.
Copy Download .nbib Format: NLM
Knowledge, attitudes and practices of healthcare professionals regarding drug-food interactions: a scoping review.

The International journal of pharmacy practice

Osuala EC, Ojewole EB.
PMID: 34355752
Int J Pharm Pract. 2021 Oct 18;29(5):406-415. doi: 10.1093/ijpp/riab049.

OBJECTIVES: Drug-food interactions (DFIs) are a problem in clinical practice as they can alter the bioavailability of drugs and nutrients and may lead to various adverse effects. Healthcare professionals (HCPs) play a significant role in counselling patients and preventing...

Cite
Osuala EC, Ojewole EB. Knowledge, attitudes and practices of healthcare professionals regarding drug-food interactions: a scoping review. Int J Pharm Pract. 2021;29(5):406-415doi: 10.1093/ijpp/riab049.
Osuala, E. C., & Ojewole, E. B. (2021). Knowledge, attitudes and practices of healthcare professionals regarding drug-food interactions: a scoping review. The International journal of pharmacy practice, 29(5), 406-415. https://doi.org/10.1093/ijpp/riab049
Osuala, Emmanuella Chinonso, and Ojewole, Elizabeth Bolanle. "Knowledge, attitudes and practices of healthcare professionals regarding drug-food interactions: a scoping review." The International journal of pharmacy practice vol. 29,5 (2021): 406-415. doi: https://doi.org/10.1093/ijpp/riab049
Osuala EC, Ojewole EB. Knowledge, attitudes and practices of healthcare professionals regarding drug-food interactions: a scoping review. Int J Pharm Pract. 2021 Oct 18;29(5):406-415. doi: 10.1093/ijpp/riab049. PMID: 34355752.
Copy Download .nbib Format: NLM
Miniaturized Drug Sensitivity and Resistance Test on Patient-Derived Cells Using Droplet-Microarray.

SLAS technology

Popova AA, Dietrich S, Huber W, Reischl M, Peravali R, Levkin PA.
PMID: 32791934
SLAS Technol. 2021 Jun;26(3):274-286. doi: 10.1177/2472630320934432. Epub 2020 Aug 13.

Testing the sensitivity of patient-derived tumor cells ex vivo can potentially help determining the appropriate treatment for each patient and spot the development of resistance to a given therapy. The number of cells obtainable from a biopsy is, however,...

Cite
Popova AA, Dietrich S, Huber W, et al. Miniaturized Drug Sensitivity and Resistance Test on Patient-Derived Cells Using Droplet-Microarray. SLAS Technol. 2020;26(3):274-286doi: 10.1177/2472630320934432.
Popova, A. A., Dietrich, S., Huber, W., Reischl, M., Peravali, R., & Levkin, P. A. (2021). Miniaturized Drug Sensitivity and Resistance Test on Patient-Derived Cells Using Droplet-Microarray. SLAS technology, 26(3), 274-286. https://doi.org/10.1177/2472630320934432
Popova, Anna A, et al. "Miniaturized Drug Sensitivity and Resistance Test on Patient-Derived Cells Using Droplet-Microarray." SLAS technology vol. 26,3 (2021): 274-286. doi: https://doi.org/10.1177/2472630320934432
Popova AA, Dietrich S, Huber W, Reischl M, Peravali R, Levkin PA. Miniaturized Drug Sensitivity and Resistance Test on Patient-Derived Cells Using Droplet-Microarray. SLAS Technol. 2021 Jun;26(3):274-286. doi: 10.1177/2472630320934432. Epub 2020 Aug 13. PMID: 32791934.
Copy Download .nbib Format: NLM
Advances in Pediatric Pharmacology, Therapeutics, and Toxicology.

Advances in pediatrics

Wang LA, Cohen-Wolkowiez M, Gonzalez D.
PMID: 27426903
Adv Pediatr. 2016 Aug;63(1):227-54. doi: 10.1016/j.yapd.2016.04.015.

No abstract available.

Cite
Wang LA, Cohen-Wolkowiez M, Gonzalez D. Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Adv Pediatr. 2016;63(1):227-54doi: 10.1016/j.yapd.2016.04.015.
Wang, L. A., Cohen-Wolkowiez, M., & Gonzalez, D. (2016). Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Advances in pediatrics, 63(1), 227-54. https://doi.org/10.1016/j.yapd.2016.04.015
Wang, Laura A, et al. "Advances in Pediatric Pharmacology, Therapeutics, and Toxicology." Advances in pediatrics vol. 63,1 (2016): 227-54. doi: https://doi.org/10.1016/j.yapd.2016.04.015
Wang LA, Cohen-Wolkowiez M, Gonzalez D. Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Adv Pediatr. 2016 Aug;63(1):227-54. doi: 10.1016/j.yapd.2016.04.015. PMID: 27426903; PMCID: PMC5050028.
Copy Download .nbib Format: NLM
Implications of gene copy-number variation in health and diseases.

Journal of human genetics

Almal SH, Padh H.
PMID: 21956041
J Hum Genet. 2012 Jan;57(1):6-13. doi: 10.1038/jhg.2011.108. Epub 2011 Sep 29.

Inter-individual genomic variations have recently become evident with advances in sequencing techniques and genome-wide array comparative genomic hybridization. Among such variations single nucleotide polymorphisms (SNPs) are widely studied and better defined because of availability of large-scale detection platforms. However,...

Cite
Almal SH, Padh H. Implications of gene copy-number variation in health and diseases. J Hum Genet. 2011;57(1):6-13doi: 10.1038/jhg.2011.108.
Almal, S. H., & Padh, H. (2012). Implications of gene copy-number variation in health and diseases. Journal of human genetics, 57(1), 6-13. https://doi.org/10.1038/jhg.2011.108
Almal, Suhani H, and Padh, Harish. "Implications of gene copy-number variation in health and diseases." Journal of human genetics vol. 57,1 (2012): 6-13. doi: https://doi.org/10.1038/jhg.2011.108
Almal SH, Padh H. Implications of gene copy-number variation in health and diseases. J Hum Genet. 2012 Jan;57(1):6-13. doi: 10.1038/jhg.2011.108. Epub 2011 Sep 29. PMID: 21956041.
Copy Download .nbib Format: NLM
[Drug access in poor countries].

Bulletin de l'Academie nationale de medecine

Sebbag R.
PMID: 18666459
Bull Acad Natl Med. 2007 Nov;191(8):1601-2.

As a responsible player in the global pharmaceutical industry, Sanofi-Aventis recognizes its special responsibility to provide poor countries with access to drugs and vaccines. This is a key component of the Group's approach to sustainable development. As such, the...

Cite
Sebbag R. Relever le défi de l'accès au médicament dans les pays du Sud. [Drug access in poor countries]. Bull Acad Natl Med. 2007;191(8):1601-2
Sebbag, R. (2007). Relever le défi de l'accès au médicament dans les pays du Sud. [Drug access in poor countries]. Bulletin de l'Academie nationale de medecine, 191(8), 1601-2.
Sebbag, Robert. "Relever le défi de l'accès au médicament dans les pays du Sud." [Drug access in poor countries]. Bulletin de l'Academie nationale de medecine vol. 191,8 (2007): 1601-2.
Sebbag R. Relever le défi de l'accès au médicament dans les pays du Sud. [Drug access in poor countries]. Bull Acad Natl Med. 2007 Nov;191(8):1601-2. French. PMID: 18666459.
Copy Download .nbib Format: NLM
[No title available]

Recenti progressi in medicina

[No authors listed]
PMID: 33624631
Recenti Prog Med. 2021 Feb;112(2):153-154. doi: 10.1701/3559.35379.

No abstract available.

Cite
Recensione.
La governance farmaceutica del dopo covid-19 nel White paper 2. . Recenti Prog Med. 2021;112(2):153-154doi: 10.1701/3559.35379.
(2021). Recensione.
La governance farmaceutica del dopo covid-19 nel White paper 2. . Recenti progressi in medicina, 112(2), 153-154. https://doi.org/10.1701/3559.35379
"Recensione.
La governance farmaceutica del dopo covid-19 nel White paper 2." . Recenti progressi in medicina vol. 112,2 (2021): 153-154. doi: https://doi.org/10.1701/3559.35379
Recensione.
La governance farmaceutica del dopo covid-19 nel White paper 2. . Recenti Prog Med. 2021 Feb;112(2):153-154. doi: 10.1701/3559.35379. Italian. PMID: 33624631.
Copy Download .nbib Format: NLM
Advances in Pediatric Pharmacology, Therapeutics, and Toxicology.

Advances in pediatrics

Wang LA, Cohen-Wolkowiez M, Gonzalez D.
PMID: 27426903
Adv Pediatr. 2016 Aug;63(1):227-54. doi: 10.1016/j.yapd.2016.04.015.

No abstract available.

Cite
Wang LA, Cohen-Wolkowiez M, Gonzalez D. Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Adv Pediatr. 2016;63(1):227-54doi: 10.1016/j.yapd.2016.04.015.
Wang, L. A., Cohen-Wolkowiez, M., & Gonzalez, D. (2016). Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Advances in pediatrics, 63(1), 227-54. https://doi.org/10.1016/j.yapd.2016.04.015
Wang, Laura A, et al. "Advances in Pediatric Pharmacology, Therapeutics, and Toxicology." Advances in pediatrics vol. 63,1 (2016): 227-54. doi: https://doi.org/10.1016/j.yapd.2016.04.015
Wang LA, Cohen-Wolkowiez M, Gonzalez D. Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Adv Pediatr. 2016 Aug;63(1):227-54. doi: 10.1016/j.yapd.2016.04.015. PMID: 27426903; PMCID: PMC5050028.
Copy Download .nbib Format: NLM
The dose of drugs--the right amount.

American heart journal

Burch GE.
PMID: 4669907
Am Heart J. 1972 Dec;84(6):842. doi: 10.1016/0002-8703(72)90082-8.

No abstract available.

Cite
Burch GE. The dose of drugs--the right amount. Am Heart J. 1972;84(6):842doi: 10.1016/0002-8703(72)90082-8.
Burch, G. E. (1972). The dose of drugs--the right amount. American heart journal, 84(6), 842. https://doi.org/10.1016/0002-8703(72)90082-8
Burch, G E. "The dose of drugs--the right amount." American heart journal vol. 84,6 (1972): 842. doi: https://doi.org/10.1016/0002-8703(72)90082-8
Burch GE. The dose of drugs--the right amount. Am Heart J. 1972 Dec;84(6):842. doi: 10.1016/0002-8703(72)90082-8. PMID: 4669907.
Copy Download .nbib Format: NLM
Showing 949 to 960 of 961 entries